CS logo
small CS logo
Rheumatology Associates of North Alabama

Huntsville, Alabama, United States
Rheumatologist in Huntsville, Alabama
720 Gallatin St SW Suite 500, Huntsville, AL 35801

About Rheumatology Associates of North Alabama


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
12
Bristol-Myers Squibb
11
Hoffmann-La Roche
4
Purdue Pharma LP
3
Galapagos NV
2
Genentech, Inc.
2
Shire
2
Ampel BioSolutions, LLC
1
Astellas Pharma Inc
1
CSL Behring
1
Crescendo Bioscience
1
Total Rows: 20

Clinical Trials at Rheumatology Associates of North Alabama


During the past decade, Rheumatology Associates of North Alabama conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 27 clinical trials were completed, i.e. on average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years55441111111100772266Started TrialsCompleted Trails2015201620172018201902468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
2002-04-01
2003-08-01
Completed
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
2002-12-01
Completed
330
Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
2002-03-01
2004-01-01
Completed
210
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
2005-07-01
2009-02-01
Completed
1,052
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
2000-04-27
2003-11-07
Completed
2,532
Open Label Extension Study of PREOS
2001-10-16
2005-04-13
Completed
1,683
The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.
1997-12-01
1998-05-01
Completed
134
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
1996-11-01
1999-12-01
Completed
225

Rows per page:

1–49 of 49

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Rheumatology Associates of North Alabama" #1 sponsor was "Pfizer" with 12 trials, followed by "Bristol-Myers Squibb" with 11 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Purdue Pharma LP" with 3 trials sponsored and "Galapagos NV" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatology Associates of North Alabama" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "IND 2 Results LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 12Pfizer: 12Bristol-Myers Squibb: 11Bristol-Myers Squibb: 11Hoffmann-La Roche: 4Hoffmann-La Roche: 4Purdue Pharma LP: 3Purdue Pharma LP: 3Galapagos NV: 2Galapagos NV: 2Genentech, Inc.: 2Genentech, Inc.: 2Shire: 2Shire: 2Ampel BioSolutions, LLC: 1Ampel BioSolutions, LLC: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1CSL Behring: 1CSL Behring: 1

Created with Highcharts 11.1.0Top CollaboratorsAstellas Pharma US, Inc.: 1Astellas Pharma US, Inc.: 1Biogen: 1Biogen: 1Gilead Sciences: 1Gilead Sciences: 1Hexal AG: 1Hexal AG: 1IND 2 Results LLC: 1IND 2 Results LLC: 1Oregon Health andScience University: 1Oregon Health andScience University: 1Roche Pharma AG: 1Roche Pharma AG: 1The Cleveland Clinic: 1The Cleveland Clinic: 1

Clinical Trials Conditions at Rheumatology Associates of North Alabama


According to Clinical.Site data, the most researched conditions in "Rheumatology Associates of North Alabama" are "Rheumatoid Arthritis" (23 trials), "Arthritis, Rheumatoid" (5 trials), "Psoriatic Arthritis" (4 trials), "Ankylosing Spondylitis" (2 trials) and "Arthritis" (2 trials). Many other conditions were trialed in "Rheumatology Associates of North Alabama" in a lesser frequency.

Clinical Trials Intervention Types at Rheumatology Associates of North Alabama


Most popular intervention types in "Rheumatology Associates of North Alabama" are "Drug" (44 trials), "Biological" (9 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Methotrexate" (10 trials), "Abatacept" (7 trials), "Tocilizumab" (3 trials) and "Tofacitinib" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Rheumatology Associates of North Alabama


The vast majority of trials in "Rheumatology Associates of North Alabama" are 46 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Rheumatology Associates of North Alabama


Currently, there are NaN active trials in "Rheumatology Associates of North Alabama". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Rheumatology Associates of North Alabama, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Rheumatology Associates of North Alabama, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 28Phase 3: 28Phase 2: 11Phase 2: 11Phase 4: 6Phase 4: 6Not Applicable: 2Not Applicable: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 44Completed: 44Terminated: 3Terminated: 3Active, not recruiting: 1Active, not recruiting: 1Unknown status: 1Unknown status: 1